TY - JOUR
T1 - Susceptibility to UV-A and UV-B provocation does not correlate with disease severity of polymorphic light eruption
AU - Janssens, Artiena Soe
AU - Pavel, Stan
AU - Ling, Tsui
AU - Winhoven, Sandra Maria
AU - Anastasopoulou, Nikoletta
AU - Stratigos, Alexander
AU - Antoniou, Christina
AU - Diepgen, Thomas
AU - De Gruijl, Frank
AU - Rhodes, Lesley Elisabeth
PY - 2007/5
Y1 - 2007/5
N2 - Objective: To examine whether the ease of disease provocation by UV-A and/or UV-B radiation correlates with clinical features of polymorphic light eruption (PLE), including those indicative of disease severity. Design: Intervention study. Patients: One hundred forty-three patients with PLE. Interventions: Provocation testing with broadband UV-A and UV-B lamps. Additionally, a range of clinical characteristics of the disorder, including a 5-item PLE severity score, was assessed by questionnaire. Main Outcome Measures: Percentage of PLE rash induction by UV-A and UV-B provocation, differences between the skin types, and correlation between the results of provocation and a range of clinical characteristics of the disorder, including a 5-item PLE severity score. Results: Rash provocation was seen in 78.3% of patients after UV-A and in 46.7% after UV-B exposure. Neither UV-A nor UV-B provocation showed a significant association with the total 5-item severity score. The UV-B reactivity was associated with a high score on the severity item "number of months affected per year" (P=.04), whereas UV-A responsiveness showed a tendency for association with facial involvement (P=.06). Conclusion: The objective assessment of UV-A or UV-B susceptibility in this large group of patients showed no significant relationship with clinical disease severity. ©2007 American Medical Association. All rights reserved.
AB - Objective: To examine whether the ease of disease provocation by UV-A and/or UV-B radiation correlates with clinical features of polymorphic light eruption (PLE), including those indicative of disease severity. Design: Intervention study. Patients: One hundred forty-three patients with PLE. Interventions: Provocation testing with broadband UV-A and UV-B lamps. Additionally, a range of clinical characteristics of the disorder, including a 5-item PLE severity score, was assessed by questionnaire. Main Outcome Measures: Percentage of PLE rash induction by UV-A and UV-B provocation, differences between the skin types, and correlation between the results of provocation and a range of clinical characteristics of the disorder, including a 5-item PLE severity score. Results: Rash provocation was seen in 78.3% of patients after UV-A and in 46.7% after UV-B exposure. Neither UV-A nor UV-B provocation showed a significant association with the total 5-item severity score. The UV-B reactivity was associated with a high score on the severity item "number of months affected per year" (P=.04), whereas UV-A responsiveness showed a tendency for association with facial involvement (P=.06). Conclusion: The objective assessment of UV-A or UV-B susceptibility in this large group of patients showed no significant relationship with clinical disease severity. ©2007 American Medical Association. All rights reserved.
U2 - 10.1001/archderm.143.5.599
DO - 10.1001/archderm.143.5.599
M3 - Article
SN - 1538-3652
VL - 143
SP - 599
EP - 604
JO - Archives of Dermatology
JF - Archives of Dermatology
IS - 5
ER -